Hyperhomocysteinemia and occlusive vascular disease: an emergent role for fibroblast growth factor 2.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 18436800)

Published in Circ Res on April 25, 2008

Authors

Miguel Angel Medina

Articles by these authors

Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol (2008) 1.72

Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge. FASEB J (2001) 1.07

Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process. Int J Cancer (2005) 1.06

Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer. Bioessays (2007) 1.05

Study of puupehenone and related compounds as inhibitors of angiogenesis. Int J Cancer (2004) 1.02

Systems biology metabolic modeling assistant: an ontology-based tool for the integration of metabolic data in kinetic modeling. Bioinformatics (2009) 1.00

When metabolism meets topology: Reconciling metabolite and reaction networks. Bioessays (2010) 0.96

Spectroscopic analysis of recombinant rat histidine decarboxylase. J Biochem (2002) 0.93

Localization of StarD5 cholesterol binding protein. J Lipid Res (2006) 0.92

Mammalian histidine decarboxylase: from structure to function. Bioessays (2005) 0.91

Effects of ursolic acid on different steps of the angiogenic process. Biochem Biophys Res Commun (2004) 0.90

Hypericin in the dark inhibits key steps of angiogenesis in vitro. Eur J Pharmacol (2005) 0.89

Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro. Br J Pharmacol (2009) 0.89

Local changes in the catalytic site of mammalian histidine decarboxylase can affect its global conformation and stability. Eur J Biochem (2003) 0.86

Anti-angiogenic effects of homocysteine on cultured endothelial cells. Biochem Biophys Res Commun (2002) 0.85

ER stress increases StarD5 expression by stabilizing its mRNA and leads to relocalization of its protein from the nucleus to the membranes. J Lipid Res (2012) 0.84

Global analysis of the human pathophenotypic similarity gene network merges disease module components. PLoS One (2013) 0.81

Targeting polyamines and biogenic amines by green tea epigallocatechin-3-gallate. Amino Acids (2009) 0.80

Protopia: a protein-protein interaction tool. BMC Bioinformatics (2009) 0.79

Homocysteine is a potent modulator of plasma membrane electron transport systems. J Bioenerg Biomembr (2008) 0.79

Targeting of histamine producing cells by EGCG: a green dart against inflammation? J Physiol Biochem (2010) 0.78

Information integration of protein-protein interactions as essential tools for immunomics. Cell Immunol (2007) 0.77

An in vitro evaluation of the effects of homocysteine thiolactone on key steps of angiogenesis and tumor invasion. Biochem Biophys Res Commun (2003) 0.77

The anti-angiogenic 8-epipuupehedione behaves as a potential anti-leukaemic compound against HL-60 cells. J Cell Mol Med (2008) 0.77

Real-time RT-PCR analysis of human histidine decarboxylase, a new marker for several types of leukemia and cancer. Oncol Rep (2006) 0.77

A novel homogenous assay for topoisomerase II action and inhibition. Chembiochem (2005) 0.76

Tetrahydrohyperforin and octahydrohyperforin are two new potent inhibitors of angiogenesis. PLoS One (2010) 0.75

A combined model of hepatic polyamine and sulfur amino acid metabolism to analyze S-adenosyl methionine availability. Amino Acids (2011) 0.75

DTD, an anti-inflammatory ditriazine, inhibits angiogenesis in vitro and in vivo. J Cell Mol Med (2008) 0.75

The pursuit of creativity in biology. Bioessays (2006) 0.75